Diabetes, Vol 46, Issue 7 1167-1171, Copyright © 1997 by American Diabetes Association

ARTICLES

Differences between the tolbutamide-boosted and the insulin-modified minimal model protocols

MF Saad, GM Steil, WW Kades, MF Ayad, WA Elsewafy, R Boyadjian, SD Jinagouda and RN Bergman
Department of Medicine, University of Southern California Medical School, Los Angeles 90033, USA. saad@hsc.usc.edu

The insulin-modified frequently sampled intravenous glucose tolerance test (FSIGTT) with minimal model analysis (MINMOD) was compared with the tolbutamide protocol and the glucose clamp in 35 nondiabetic subjects (age 38 +/- 2 years [mean +/- SE], BMI 27.2 +/- 0.9 kg/m2). Each subject underwent two FSIGTTs, one with tolbutamide (300 mg) and the other with insulin (0.03 U/kg) and a euglycemic hyperinsulinemic clamp (40 mU x m(-2) x min(-1)). Insulin sensitivity was determined from each FSIGTT with MINMOD and from the clamp. Insulin sensitivity indexes (S(I)) from the two FSIGTTs were significantly correlated (r = 0.77, P < 0.001), but S(I(insulin)) was 29 +/- 4% lower than S(I(tolbutamide)). Both S(I(insulin)) and S(I(tolbutamide)) correlated significantly with S(I(clamp)) (r = 0.70 and 0.71, P < 0.001 for each). Expressed in the same units (dl/min per pU/ml), S(I(tolbutamide)) was on average 13 +/- 6% lower than S(I(clamp)) (4.51 +/- 0.40 vs. 5.36 +/- 0.36 x 10(-2), P = 0.009), whereas S(I(insulin)) was 44 +/- 4% lower. S(G(tolbutamide)) and S(G(insulin)) were not different (1.88 +/- 0.10 vs. 2.01 +/- 0.09 x 10(-2) min(-1), P = 0.167) and were significantly correlated (r = 0.50, P = 0.002). Thus, insulin sensitivity estimates from both protocols correlate significantly with each other and with the clamp. They are quantitatively discrepant, however, possibly due to differences in the route of insulin delivery, saturation of insulin action, and/or tolbutamide-induced proinsulin release. Data obtained from these two MINMOD protocols are not directly comparable, and the same protocol must be used in any single cross-sectional or longitudinal study.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Yao-Borengasser, N. Rasouli, V. Varma, L. M. Miles, B. Phanavanh, T. N. Starks, J. Phan, H. J. Spencer III, R. E. McGehee Jr., K. Reue, et al. Lipin Expression Is Attenuated in Adipose Tissue of Insulin-Resistant Human Subjects and Increases With Peroxisome Proliferator-Activated Receptor {gamma} Activation. Diabetes, October 1, 2006; 55(10): 2811 - 2818. [Abstract] [Full Text] [PDF]

				S. K. Das, W. S. Chu, T. C. Hale, X. Wang, R. L. Craig, H. Wang, A. R. Shuldiner, P. Froguel, P. Deloukas, M. I. McCarthy, et al. Polymorphisms in the Glucokinase-Associated, Dual-Specificity Phosphatase 12 (DUSP12) Gene Under Chromosome 1q21 Linkage Peak Are Associated With Type 2 Diabetes Diabetes, September 1, 2006; 55(9): 2631 - 2639. [Abstract] [Full Text] [PDF]

				A. Brehm, K. Thomaseth, E. Bernroider, P. Nowotny, W. Waldhausl, G. Pacini, and M. Roden The Role of Endocrine Counterregulation for Estimating Insulin Sensitivity from Intravenous Glucose Tolerance Tests J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2272 - 2278. [Abstract] [Full Text] [PDF]

				C. Dalla Man, K. E. Yarasheski, A. Caumo, H. Robertson, G. Toffolo, K. S. Polonsky, and C. Cobelli Insulin sensitivity by oral glucose minimal models: validation against clamp Am J Physiol Endocrinol Metab, December 1, 2005; 289(6): E954 - E959. [Abstract] [Full Text] [PDF]

				M. R. Batista, M. S. Smith, W. L. Snead, C. C. Connolly, D. B. Lacy, and M. C. Moore Chronic estradiol and progesterone treatment in conscious dogs: effects on insulin sensitivity and response to hypoglycemia Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2005; 289(4): R1064 - R1073. [Abstract] [Full Text] [PDF]

				G. B. Di Gregorio, A. Yao-Borengasser, N. Rasouli, V. Varma, T. Lu, L. M. Miles, G. Ranganathan, C. A. Peterson, R. E. McGehee, and P. A. Kern Expression of CD68 and Macrophage Chemoattractant Protein-1 Genes in Human Adipose and Muscle Tissues: Association With Cytokine Expression, Insulin Resistance, and Reduction by Pioglitazone Diabetes, August 1, 2005; 54(8): 2305 - 2313. [Abstract] [Full Text] [PDF]

				K. M. Krudys, M. G. Dodds, S. M. Nissen, and P. Vicini Integrated model of hepatic and peripheral glucose regulation for estimation of endogenous glucose production during the hot IVGTT Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E1038 - E1046. [Abstract] [Full Text] [PDF]

				A. Bitnun, E. Sochett, P. T. Dick, T. To, C. Jefferies, P. Babyn, J. Forbes, S. Read, and S. M. King Insulin Sensitivity and {beta}-Cell Function in Protease Inhibitor-Treated and -Naive Human Immunodeficiency Virus-Infected Children J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 168 - 174. [Abstract] [Full Text] [PDF]

				K. L. Teff and R. R. Townsend Prolonged Mild Hyperglycemia Induces Vagally Mediated Compensatory Increase in C-Peptide Secretion in Humans J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5606 - 5613. [Abstract] [Full Text] [PDF]

				G. M. Steil, C.-m. Hwu, R. Janowski, F. Hariri, S. Jinagouda, C. Darwin, S. Tadros, K. Rebrin, and M. F. Saad Evaluation of Insulin Sensitivity and {beta}-Cell Function Indexes Obtained From Minimal Model Analysis of a Meal Tolerance Test Diabetes, May 1, 2004; 53(5): 1201 - 1207. [Abstract] [Full Text] [PDF]

				T. O'Connell and D. R. Clemmons IGF-I/IGF-Binding Protein-3 Combination Improves Insulin Resistance By GH-Dependent and Independent Mechanisms J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4356 - 4360. [Abstract] [Full Text] [PDF]

				H. Huopio, I. Vauhkonen, J. Komulainen, L. Niskanen, T. Otonkoski, and M. Laakso Carriers of an Inactivating {beta}-Cell ATP-Sensitive K+ Channel Mutation Have Normal Glucose Tolerance and Insulin Sensitivity and Appropriate Insulin Secretion Diabetes Care, January 1, 2002; 25(1): 101 - 106. [Abstract] [Full Text] [PDF]

				M. J. Quon Limitations of the Fasting Glucose to Insulin Ratio as an Index of Insulin Sensitivity J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4615 - 4617. [Full Text] [PDF]

				S. Gill, A. E. Taylor, K. A. Martin, C. K. Welt, J. M. Adams, and J. E. Hall Specific Factors Predict the Response to Pulsatile Gonadotropin-Releasing Hormone Therapy in Polycystic Ovarian Syndrome J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2428 - 2436. [Abstract] [Full Text] [PDF]

				A. Katz, S. S. Nambi, K. Mather, A. D. Baron, D. A. Follmann, G. Sullivan, and M. J. Quon Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2402 - 2410. [Abstract] [Full Text]

				C. McDonald, A. Dunaif, and D. T. Finegood Minimal-Model Estimates of Insulin Sensitivity Are Insensitive to Errors in Glucose Effectiveness J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2504 - 2508. [Abstract] [Full Text]

				B. Ahren and G. Pacini Dose-related effects of GLP-1 on insulin secretion, insulin sensitivity, and glucose effectiveness in mice Am J Physiol Endocrinol Metab, December 1, 1999; 277(6): E996 - E1004. [Abstract] [Full Text] [PDF]

				A. Caumo, P. Vicini, J. J. Zachwieja, A. Avogaro, K. Yarasheski, D. M. Bier, and C. Cobelli Undermodeling affects minimal model indexes: insights from a two-compartment model Am J Physiol Endocrinol Metab, June 1, 1999; 276(6): E1171 - E1193. [Abstract] [Full Text] [PDF]

				R. V. Hogikyan, A. T. Galecki, B. Pitt, J. B. Halter, D. A. Greene, and M. A. Supiano Specific Impairment of Endothelium-Dependent Vasodilation in Subjects with Type 2 Diabetes Independent of Obesity J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 1946 - 1952. [Abstract] [Full Text]

				G. Pacini, G. Tonolo, M. Sambataro, M. Maioli, M. Ciccarese, E. Brocco, A. Avogaro, and R. Nosadini Insulin sensitivity and glucose effectiveness: minimal model analysis of regular and insulin-modified FSIGT Am J Physiol Endocrinol Metab, April 1, 1998; 274(4): E592 - E599. [Abstract] [Full Text] [PDF]

				A. Rostami-Hodjegan, S. R. Peacey, E. George, S. R. Heller, and G. T. Tucker Population-based modeling to demonstrate extrapancreatic effects of tolbutamide Am J Physiol Endocrinol Metab, April 1, 1998; 274(4): E758 - E771. [Abstract] [Full Text] [PDF]